CymoGen Dx Overview
- Founded
- 2010
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
CymoGen Dx General Information
Description
Provider of research products for clinical, research and biopharmaceutical customers. The company engages in the application of fluorescence-based DNA detection technology and provides tools for identifying genomic aberrations in cancer cells found in tissue and bone marrow specimens.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Monitoring Equipment
Acquirer
Primary Office
- 4 Crotty Lane
- Suite 100
- New Windsor, NY 12553
- United States
+1 (845) 000-0000
CymoGen Dx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 09-Mar-2015 | 00000 | Completed | Generating Revenue | ||
| 1. Angel (individual) | 06-Jul-2010 | 00000 | 00000 | Completed | Startup |